Optometrists in Morgan City, LA Accepting Medicare

5 Optometrists found. Showing 1 - 5

Lee H. Craddock O.d. Apoc Optometrist Medicare: Medicare Enrolled Practice Location: 973 Highway 90 E, Morgan City, LA 70380 Phone: 985-395-7219

St. Mary Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 1301 Victor Ii Blvd Ste B, Morgan City, LA 70380 Phone: 985-385-5744    Fax: 985-384-6194

Keith M Comeaux, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1301 Victor Ii Blvd Ste B, Morgan City, LA 70380 Phone: 985-385-5744    Fax: 985-384-6194

Kidd Vision Center Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1301 Victor Ii Blvd Ste B, Morgan City, LA 70380 Phone: 985-385-5744

Dr. Lee H. Craddock, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 973 Hwy 90 E, Morgan City, LA 70380 Phone: 985-395-7219    Fax: 985-395-7723

News Archive

IMGM acquires 3,100,000 Class B Preferred Shares of Positron

The Shareholders of Imagin Molecular Corporation ("IMGM") have approved, through a consent of over 51% of shareholder vote, certain transactions wherein IMGM completed the acquisition of 3,100,000 Class B Preferred Shares of Positron Corporation which shares are convertible on a 1 for 100 basis into Positron common shares.

Researchers at the University of Southampton develop new social networking tool

Researchers at the University of Southampton have developed a new social networking tool that users have described as not only improving reflection and awareness of their own well-being, but also raising their interest in others.

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

Chemically altered osteoporosis drug may fight malaria

A chemically altered osteoporosis drug may be useful in fighting malaria, researchers report in a new study. Unlike similar compounds tested against other parasitic protozoa, the drug readily crosses into the red blood cells of malaria-infected mice and kills the malaria parasite. The drug works at very low concentrations with no observed toxicity to the mouse.

Read more Medical News

› Verified 6 days ago